INSUBCONTINENT EXCLUSIVE:
Kathmandu, October 15
Though the Department of Drug Administration, Nepal drug regulatory authority, has directed all pharmaceutical
manufacturers and suppliers to avoid N-nitrosodimethylamine impurity in ranitidine, the department itself doesn''t have equipment to conduct
